This past June, the FDA sent out 25 warning letters to telehealth companies selling compounded semaglutide and ...
The FDA is considering allowing compounding pharmacies to make six peptides. Research on wellness peptides like BPC-157 and TB-500 is largely limited to animal studies, with little evidence that ...
A few years ago, Omar Rahman, MD, rarely heard the word “peptide” in an orthopedic exam room. Now patients arrive asking about BPC-157, TB-500 and growth-hormone-related compounds after hearing about ...
An FDA advisory committee has voted by a majority to recommend broader access to certain peptides. Peptides are short chains ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. An FDA advisory panel recommended that six ...
Ivím Health reports a federal panel has recommended BPC-157, a popular peptide, be available through licensed compounding ...
Ottawa Citizen on MSN
Could compounding pharmacies solve Ontario's drug shortage?
Laurie Proulx has relied on medication to manage the pain of a chronic illness she’s been living with for decades.
Children's hospitals manage drug shortages by addressing unique pediatric needs and operational challenges to ensure safe, effective care.
For decades, the friction between a prescription and a patient was accepted as part of the process. Now, pharmacy leaders are closing that gap with AI because “to wait one moment longer is untenable.” ...
Jody Agena, PharmD, discusses staffing, communication, and operational readiness for implementing complex oncology therapies. Pharmacy workflows, operationalization, and implementation are important ...
When patients fill a prescription at their local pharmacy, they’re usually getting a drug that has been through years of clinical trials to make sure it’s safe and effective. The system is not perfect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results